Beijing Tiantan Biological Products financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥290.05M ¥343.36M ¥416.76M ¥530.50M ¥967.75M ¥1.10B ¥1.20B ¥1.39B ¥1.50B ¥1.84B ¥1.83B ¥1.62B ¥2.14B ¥2.48B ¥2.93B ¥3.28B ¥3.45B ¥4.11B ¥4.26B ¥5.18B ¥0.00M
GM % Gross Margin %
50.21% 55.72% 55.04% 61.77% 62.92% 63.33% 57.60% 59.19% 55.62% 54.26% 54.81% 43.44% 51.74% 51.13% 46.71% 49.50% 49.47% 47.40% 49.02% 50.72% 0.00%
OM Operating Margin
20.42% 26.94% 30.31% 35.65% 34.20% 34.08% 22.81% 26.85% 29.76% 31.59% 21.82% 18.13% 20.87% 31.10% 29.03% 31.13% 30.44% 28.55% 30.34% 32.93% 0.00%
EPS Earnings Per Share
¥0.05 ¥0.07 ¥0.08 ¥0.09 ¥0.10 ¥0.11 ¥0.15 ¥0.18 ¥0.24 ¥0.08 ¥-0.01 ¥0.28 ¥0.34 ¥0.40 ¥0.42 ¥0.48 ¥0.52 ¥0.67 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.08 ¥0.05 ¥0.00 ¥0.00 ¥0.03 ¥0.03 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.09 ¥0.03 ¥0.04 ¥0.08 ¥0.08 ¥0.05 ¥0.15 ¥0.00
PR % Payout Ratio %
0 0 114.29% 62.50% 0 0.00% 27.27% 20.00% 0.00% 0.00% 0.00% -0.00% 0 32.14% 8.82% 10.00% 19.05% 16.67% 9.62% 22.39% 0
Sha. Shares
1188.21m 1188.21m 1188.21m 1188.21m 1188.21m 1188.21m 1188.21m 1254.44m 1254.44m 1254.44m 1254.44m 1254.44m 1254.44m 1254.44m 1254.44m 1254.44m 1505.33m 1254.44m 1373.17m 0m 1647.81m
OCF Operating Cash Flow
¥110.11M ¥131.69M ¥154.36M ¥153.55M ¥367.08M ¥448.23M ¥184.85M ¥353.15M ¥432.00M ¥566.43M ¥477.95M ¥473.26M ¥432.98M ¥138.47M ¥677.92M ¥642.47M ¥702.11M ¥980.35M ¥1.13B ¥2.39B ¥0.00M
FCF Free Cash Flow
¥24.22M ¥91.91M ¥82.86M ¥87.15M ¥187.70M ¥257.06M ¥-112.69M ¥-365.16M ¥-125.87M ¥18.06M ¥13.79M ¥172.69M ¥215.57M ¥78.74M ¥384.30M ¥133.11M ¥93.81M ¥-142.84M ¥-228.02M ¥1.32B ¥0.00M
FCFS Free Cash Flow Per Share
¥0.02 ¥0.08 ¥0.07 ¥0.07 ¥0.15 ¥0.21 ¥-0.09 ¥-0.29 ¥-0.10 ¥0.01 ¥0.01 ¥0.14 ¥0.17 ¥-0.06 ¥0.31 ¥0.09 ¥0.07 ¥-0.09 ¥-0.14 ¥0.79 ¥0.00